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OBJECTIVE — In the face of ﬁnancial constraints, diabetic patients may forgo prescribed
medications, causing negative health effects. This study examined how cost and noncost factors
are associated with patterns of cost-related nonadherence to medications (CRN).
RESEARCH DESIGN AND METHODS — This was a cross-sectional survey of patients
using medications for both diabetes and chronic pain (n  245). Patients reported their income,
out-of-pocket medication costs, education level, depressive symptoms, and medication-related
beliefs and whether they cut back because of cost on 1) both diabetes and pain medications, 2)
diabetes medications only, 3) pain medications only, or 4) neither. Multinomial logistic regres-
sion was used to model patients’ adjusted odds ratios (AORs) of falling into these four possible
categories.
RESULTS — Of the patients, 9% cut back on medications for both conditions, 13% cut back
on diabetes medications alone, and 9% cut back on pain medications alone. Income 20,000
USD (AOR  5.7, P  0.008) and monthly medication costs 50 USD (AOR  3.9, P  0.02)
increased patients’ odds of CRN for both conditions versus neither. Low-income patients also
were more likely to selectively forgo pain medications (AOR  9.1, P  0.001) but not diabetes
medications (AOR  2.1, P  0.12). More depressive symptoms (AOR  1.6, P  0.006) and
negative medication-related beliefs (AOR  1.7, P  0.02) increased patients’ odds of cutting
back selectively on medications for diabetes but not pain.
CONCLUSIONS — Patients who forgo medications for both diabetes and chronic pain
appear to be inﬂuenced primarily by economic pressures, whereas patients who cut back selec-
tively on their diabetes treatments are inﬂuenced by their mood and medication beliefs. Our
ﬁndings point toward more targeted strategies to assist diabetic patients who experience CRN.
Diabetes Care 32:2143–2148, 2009
P
rescription drug spending in 2007
was 750 USD per capita in the
U.S., of which patients must pay a
growing share through medication co-
payments (1,2). Nine of 10 older adults
use prescription medications, and those
with Medicare Part D take ﬁve prescrip-
tions per month on average (3). Even
among low-income patients, most take
their medications despite copayments
(4); however, one-ﬁfth or more of all
patients may cut back because of cost
concerns (5,6). Cost-related nonadher-
ence to medications (CRN) has been as-
sociated with increased rates of serious
adverse events, emergency department
visits, hospitalizations, and poorer
health (7,8).
Empirical studies have implicated ﬁ-
nancial, attitudinal, mood, and provider
inﬂuences in CRN, although their relative
effects are not well understood (4,9).
Mostofthevarianceinpatients’reportsof
CRN remains unexplained by ﬁnancial
measures (10). Although economic pres-
sures drive these decisions, noncost fac-
tors appear to modify the effect of
medication cost at a given level of ability
to pay (11).
Most survey-based studies of CRN
have used a single global question to as-
certain adherence and, therefore, could
not discern whether patients cut back
uniformly across their medications or se-
lectively (6,7,12–14). Studies using ad-
ministrative data indicate that patients
vary in their adherence across medica-
tions, but these studies could not explore
fully the inﬂuences of factors such as pa-
tients’ mood and medication-related be-
liefs (15,16).
Building on our theoretical model of
factorsthatinﬂuencepatients’elasticityof
demand for prescription drugs (9), in the
present study we explored further how
cost and noncost factors inﬂuence pa-
tients’ adherence to prescription medica-
tions for two chronic conditions: type 2
diabetes and chronic pain. We hypothe-
sized that although some patients would
cut back on medications for both condi-
tions, others would cut back selectively,
and sought to understand the factors as-
sociated with these behaviors.
These analyses are important for clin-
ical care because most efforts to address
CRN have targeted patients’ ability to pay
exclusively,forexample,throughgovern-
ment assistance (e.g., Medicare Part D),
pharmaceutical industry programs, and
prescribing of less expensive therapeutic
alternatives (10). Physicians are now
called upon to incorporate discussions of
medication cost pressures into their rou-
tine patient interactions (17). Because in-
sufﬁcient time may be the greatest barrier
to such provider-initiated discussions
(17), it is essential that we distinguish pa-
tientsforwhomabilitytopay,asopposed
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challenge to adherence.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted in Flint, Michigan, an economi-
cally distressed, mid-sized city, as part of
a larger study of medication cost prob-
lems among low-income patients with di-
abetes. Patients were identiﬁed through
general medicine clinics of a large safety-
net health system (17% of participants),
its afﬁliated diabetes education center
(58%), and the local network of federally
qualiﬁed health centers (25%). Patients
wereeligibleforthestudyiftheyhadtype
2 diabetes, used antihyperglycemia med-
ication, had not been hospitalized in the
prior 3 years for a serious psychiatric ill-
ness, and received most of their diabetes
care in one of the participating clinical
sites. Between July 2005 and December
2007, 3,800 patients (92%) were identi-
ﬁed from medical records using diagnos-
tic codes and contacted by phone, and
322 (8%) were identiﬁed at outpatient
visits. Of this pool of 4,122 patients with
an attempted contact, 2,516 could not be
reached, 450 refused, and 1,116 were
screened. A total of 841 screened patients
were determined to be eligible, and of
these, 806 (96%) completed an informed
consent form and data collection via de-
tailed in-person interviews with trained
surveyors.Thecurrentstudyisbasedona
subsetof245patientswhoreportedusing
medications for chronic pain (arthritis,
migraines, back pain, or sciatica) and di-
abetes (oral antihyperglycemia drugs or
insulin). The study was approved by in-
stitutionalreviewboardsatallinstitutions
involved.
Data collection and variable creation
Cost-related underuse of medications.
Patients’ CRN was measured using three
itemssimilartothoseusedinpriorstudies
(5,11): “In the past 12 months, have you
ever taken less of your [insert either “in-
sulin,” “diabetes pills,” or “medication for
chronic pain”] than prescribed because of
the cost?” (yes/no for each). Patients were
considered to have CRN for diabetes if
they reported underuse of either diabetes
pills or insulin. Based on their responses,
patients were categorized into four
groups:1)CRNforbothchronicpainand
diabetesmedications,2)CRNfordiabetes
medications only, 3) CRN for chronic
pain medications only, or 4) CRN for nei-
ther medication type.
Medication-related beliefs and infor-
mation. Patients’ beliefs about prescrip-
tion medications were measured using a
composite score based on items from the
Beliefs about Medications Questionnaire
(18). A factor analysis was performed on
the eight items from the original scale,
which showed one independent factor
with eigenvalue 1. A subscale using the
questions in which the rotated factor
loadings exceeded 0.4 for the factor was
created. To increase subscale reliability,
individual items were sequentially
dropped until the  value was maximized
(0.68). The statements included in the re-
sultant scale were, “Doctors use too many
prescription medications,” “Prescription
medications do more harm than good,”
“Doctorsplacetoomuchtrustinprescrip-
tion medications,” and “If doctors had
more time with patients they would pre-
scribe fewer prescription medications.”
Patientsindicatedtheirlevelofagreement
witheachstatementusinga3-pointLikert
scale of “agree,” “unsure,” and “disagree.”
To improve interpretability in regression
models, this scale was standardized. In
additiontothesegeneralbeliefsitems,the
BMQ includes subscales addressing per-
ceived necessity and concerns regarding
speciﬁc medication types; these were not
used in the current study because of the
complexity of addressing these domains
simultaneously for the two medication
types in the context of the other predic-
tors of interest.
Patients’ satisfaction with the infor-
mation they received about their medica-
tions was measured using a modiﬁed
version of the Satisfaction with Informa-
tion about Medications Scale (19). This
16-item scale asked patients to report the
extent (“enough” versus “not enough”) to
which they are satisﬁed with the informa-
tion they had received “from [their] doc-
tors and other people working in the
place where [they] get medical care” on
topics such as “how [their] medications
work” and “how to use [their] medica-
tions.”Thesummarymeasurehadanof
0.96. Because 43% of patients indicated
the highest level of satisfaction with med-
ical information, the scale was dichoto-
mized as complete versus incomplete
satisfaction with medication information.
Other variables. Patients reported their
age, sex, race/ethnicity, years of formal
education, household income from all
sources, monthly out-of-pocket cost for
prescription medications, insurance sta-
tus,anddepressionsymptoms.Before-tax
employment income and income from all
other sources were reported separately
using ordinal categories, and the mid-
points within each of the two ranges were
used to estimate patients’ total income.
Out-of-pocket medication costs were re-
ported using ordinal categories that were
dichotomized near the median to create
an indicator of monthly out-of-pocket
costs 50 vs. 50 USD. Depressive
symptoms were measured using the Pa-
tientHealthQuestionnaire(PHQ-9)(20).
A1C was measured at the time of survey
via ﬁngerstick and a point-of-care ana-
lyzer.
Statistical analysis
We examined unadjusted differences
across groups deﬁned by patients’ socio-
demographic characteristics, medication-
related beliefs, and levels of depressive
symptoms in the distribution of patients
acrossthefourcategoriesofCRNusing
2
tests. We then constructed a multinomial
logistic regression model in two stages
with the four-level CRN measure as the
dependent variable. First we limited the
modeltofactorsrelatedtopatients’ability
to pay for medications: income, out-of-
pocket costs, and patient education. The
second model included these measures as
well as measures of potentially mutable
factors: satisfaction with medical infor-
mation,depressivesymptoms,andbeliefs
about prescription medications. Demo-
graphicvariableswerenotincludedinthe
models because they have previously
been found to have little inﬂuence on
CRN (4), a ﬁnding consistent with our
bivariate results (Table 1). A1C and pain
severity were excluded from the models
because they are as likely to be a conse-
quence as a cause of CRN. A likelihood-
ratio test comparing the two models
favored the second (
227.24,d.f.9,
P0.001),resultsofwhicharereported.
Differencesintheinﬂuenceofagivenpre-
dictor (as measured by the adjusted odds
ratio [AOR]) between logit functions
within the model were examined using
Wald tests. The variance inﬂation factor
was calculated for the ﬁnal regression
model and did not show signiﬁcant mul-
ticollinearity(meanvarianceinﬂationfac-
tor  1.09, range 1.02–1.21). The
multinomial logistic regression model
was repeated after CRN was deﬁned for
diabetes as underuse of diabetes pills,
without consideration of insulin. There
were no signiﬁcant changes in the results.
We also explored alternative models con-
trolling for patients’ overall number of
medications and number of medications
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and hyperlipidemia) as potential con-
founders. These medication variables had
nostatisticallysigniﬁcantindependentef-
fects on CRN for diabetes or pain treat-
ments and little discernible impact on
other associations illustrated by the mul-
tivariatemodel.Herewepresentthemore
parsimonious model without these
covariates.
Multinomial logistic regression si-
multaneously estimates multiple binary
logisticregressionmodelsforoutcomesof
a nominal variable using one base cate-
gory. The group without any CRN was
used as the referent group.
Toillustratetheimpactofonekeypa-
tient characteristic (i.e., depressive symp-
toms)onCRNbehavior,wecalculatedthe
predicted probability distribution for two
hypothetical groups of patients with min-
imal depression (PHQ-9  2) and severe
depression (PHQ-9  25), holding all
othercovariatesattheirmeanvalues(20).
AnalyseswereperformedusingStata10.0
(StataCorp, College Station, TX).
RESULTS
Sample characteristics and
associations with CRN categories
Patients were, on average, aged 55 years
and predominantly women (72%) and
African American (60%) with reasonably
good glycemic control (46% with A1C
7%). Most had out-of-pocket medica-
tion costs 50 USD per month (71%),
household income 20,000 USD (56%),
and at most a high school education
(56%). Roughly 3 of 5 patients (59%)
were less than completely satisﬁed with
informationtheyhadreceivedabouttheir
medications, and 1 of 10 (10%) had at
least moderately severe depression
(PHQ-9 15).
Roughly equal numbers of patients
reported CRN for both diabetes and pain
(8.6%) and for pain only (9%) (Table 1).
Patients who cut back selectively on their
diabetes medications were the largest un-
deruse group (13.1%). Most patients did
not report CRN for either condition
(69.4%).
The age, sex, race, and educational
achievement of patients across the four
categories of CRN were roughly similar.
Patients with higher A1Cs were more
likely to underuse their diabetes medica-
tions, either alone or in combination with
theirpaintreatment(P0.002).Patients’
income was signiﬁcantly associated with
their adherence behavior (P  0.001).
Compared with higher-income patients,
lower-incomepatientswerethreetimesas
likely to cut back on both medication
types (13.1%) and selectively on chronic
pain medications (12.4%) but only
slightly more likely to cut back only on
their diabetes medications (14.6%).
Patientswhowerenotcompletelysat-
isﬁed with the information they had re-
ceivedabouttheirmedicationsweremore
likely to cut back selectively on their dia-
betes medications (16.6 vs. 8%) and on
their pain medications only (11.7 vs. 4%)
because of cost compared with patients
who were completely satisﬁed. Among
less depressed patients, 9.3% reported
CRN for both medication types, 11.1%
for diabetes only, and 8.8% for pain med-
ications only. In contrast, patients with at
least moderately severe depression were
half as likely to report CRN for both con-
ditions (4.4%), and nearly three times as
likely to report underuse for diabetes
medications only (30.4%). Patients who
had more negative beliefs about prescrip-
tion drugs were less likely to cut back on
bothtypesofmedications(5.7vs.13.5%)
and more likely to cut back on diabetes
medications only (17.9 vs. 6.7%).
Multinomial logistic regression
model
In the logistic model (Table 2), lower-
income patients were more likely to re-
port CRN for both conditions (AOR 
5.7,P0.008)andforpainonly(AOR
9.1, P  0.001) but not to cut back selec-
tivelyondiabetesmedications(OR2.1,
P  0.12). Higher costs were associated
with higher odds that patients would re-
Table 1—Patient characteristics and association with adherence category
CRN for
both
CRN for
diabetes
CRN for
pain No CRN P
9.0 13.1 8.6 69.4 NA
Age
55 years 13.1 12.3 9.8 64.8 0.11
55 years 4.9 13.8 7.3 74.0
Sex
Female 7.3 14.7 7.3 70.6 0.22
Male 13.2 8.8 11.8 66.2
Race
Nonwhite 10.3 15.8 7.5 66.4 0.27
White 6.2 9.4 10.4 74.0
Education
12th grade 9.6 11.1 6.7 72.6 0.36
12th grade 7.5 15.9 11.2 65.4
A1C
7% 5.3 8.0 9.8 76.7 0.002
7% 12.1 17.4 6.8 63.6
Annual income (USD)
20,000 13.1 14.6 12.4 59.8 0.001
20,000 3.7 11.1 3.7 81.5
Medication costs (USD)
50/month 7.5 12.1 8.7 71.7 0.46
50/month 12.9 15.7 8.6 62.9
Medical information satisfaction
Incomplete 6.2 16.6 11.7 65.5 0.01
Complete 13.0 8.0 4.0 75.0
PHQ-9 depression score
15 9.3 11.1 8.8 70.8 0.07
15 4.4 30.4 8.7 56.5
Negative medication beliefs
Median 13.5 6.7 7.7 72.1 0.02
Median 5.7 17.9 9.3 67.1
Data are row percents. n  245. 
2 tests were used to calculate P values. Satisfaction with information about
medications was deﬁned as complete if patients reported that they had enough information in every topic
area listed in the modiﬁed Satisfaction with Information about Medications Scale. The depression scale used
was the PHQ-9; 15 on the scale corresponds to at least moderately severe depression. Prescription med-
ication beliefs were reported using a subscale generated from the Beliefs about Medications Questionnaire.
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(OR3.9,P0.02)butdidnotincrease
patients’ likelihood of cutting back selec-
tively on one or the other medication
type.
Depressive symptoms, negative med-
ication-related beliefs, and dissatisfaction
with information about medications were
not signiﬁcantly associated with cutting
back on both treatment types. However,
the odds that patients would selectively
cut back on their pain medications was
greater among patients reporting dissatis-
faction with information about medica-
tions (AOR  3.4, P  0.04). A 5-point
increase on the PHQ-9 depression scale
increased the odds that patients would
cut back selectively on their diabetes
medications by a factor of 1.65 (P 
0.006). Patients with more depressive
symptoms were more likely to cut back
selectively on their diabetes medications
than on their pain medications only (P 
0.01).A1-SDincreaseonthescaleofneg-
ative medication beliefs increased pa-
tients’ likelihood of cutting back
selectivelyontheirdiabetestreatmentrel-
ative to not cutting back at all (AOR 
1.7, P  0.02). Patients with more nega-
tivemedicationbeliefsweremorelikelyto
cut back on their diabetes medications
only than to cut back on both medication
types (P value of the Wald test  0.031).
Figure 1 shows the predicted proba-
bility distribution of patients across CRN
categorieswithingroupsofnondepressed
and depressed patients. The overall pro-
portion of patients with some CRN is
higher among those with more severe de-
pressive symptoms (54 vs. 21%, P 
0.05). This difference reﬂects a greater
number of depressed patients forgoing
their diabetes medications only (42 vs.
7%,P0.05)ratherthancuttingbackon
their pain medications only or across the
board.
CONCLUSIONS— In this study,
lower income and higher out-of-pocket
medication costs signiﬁcantly increased
the odds that diabetic patients would re-
port CRN for both diabetes and chronic
pain; lower income also increased pa-
tients’ likelihood of cutting back on
chronic pain medications alone. In con-
trast, neither of these indicators of pa-
tients’ ﬁnancial pressure was signiﬁcantly
associated with selective underuse of dia-
betes medications. Rather, selective un-
deruse of diabetes medications due to
“cost”wasassociatedwithdepressionand
negative beliefs about pharmacotherapy.
Dissatisfaction with information about
medications—but not depressive symp-
toms—increased the likelihood that a pa-
tient would report selectively foregoing
his or her pain treatment.
This is one of the ﬁrst studies to in-
vestigate patient factors affecting CRN for
multiple chronic conditions simulta-
neously (15). Most previous studies have
treated CRN as a global patient-level be-
havior (14,17) or have used administra-
tive data (4,13), with limited ability to
linkpatients’adherencechoiceswithpos-
sible determinants such as their depres-
sive symptoms or medication-related
beliefs.However,theresultsherearecon-
sistent with prior studies also suggesting
that patients value their various medica-
tions differently, thereby differentially af-
fecting the elasticity of demand for
speciﬁc medications (21).
The current study adds to the evi-
dence (6,16,21) that patients selectively
forgo medications because of cost and are
inﬂuenced in those decisions by noncost
factors, such as beliefs, satisfaction with
medication-related information, and de-
pressed mood. Those who forgo medica-
Figure 1—Predicted probability of CRN among diabetic patients with chronic pain, with and
without depressive symptoms. Predicted probabilities were generated using the multinomial lo-
gistic regression model shown in Table 2. For minimal depression, the PHQ-9 scale score was set
at 2 and for severe depression was set at 25. All other covariates were held at their mean values.
* , diabetes; p, pain; f, both; *z, neither. *P  0.05 for difference in probability between
minimally and severely depressed patients.
Table 2—Multinomial logistic regression results
CRN for both CRN for diabetes CRN for pain
Income 20,000 USD 5.74 (1.58–20.88)* 2.11 (0.82–5.47) 9.06 (2.44–33.60)*
Monthly medication costs
50 USD 3.90 (1.29–11.78)* 1.86 (0.71–4.83) 2.11 (0.67–6.64)
12th grade education 1.15 (0.41–3.27) 1.42 (0.61–3.32) 2.44 (0.89–6.74)
Dissatisfaction with medical
information 0.59 (0.22–1.61)† 1.97 (0.79–4.89) 3.41 (1.04–11.13)*
PHQ-9 depression score 1.29 (0.84–2.01) 1.65 (1.15–2.36)* 0.81 (0.50–1.31)‡
Negative medication beliefs 0.85 (0.52–1.40)‡ 1.67 (1.08–2.57)* 1.12 (0.69–1.85)
Data are AORs (95% CI). Base category is the group of patients without CRN for either diabetes or chronic
pain. Dissatisfaction with medical information is an indicator for whether the patient was above the median
on the modiﬁed Satisfaction with Information about Medications Scale. AORs for the PHQ-9 depression
score represent the effect of a 5-point increase in the PHQ-9. For negative prescription beliefs, AORs
represent the effect of a 1-SD increase in the subscale created from the Beliefs about Medications Question-
naire. *P  0.05 for the AOR relative to the base group (no CRN). †P  0.05 for the difference between the
AOR and the AOR for “CRN for pain.” ‡P  0.05 for the difference between the AOR and the AOR for “CRN
for diabetes.”
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show the greatest sensitivity to factors re-
latedtoabilitytopay(e.g.,incomeorout-
of-pocket prescription costs).
Proposed measures to deal with ﬁ-
nancialpressures,suchasprescribingless
expensive medications and pharmaceuti-
cal company assistance programs, may be
ineffective for patients whose predomi-
nant reasons for CRN are negative beliefs
about medications or depressed mood.
Physicians and other health care provid-
ers (e.g., pharmacists and care managers)
should ask patients speciﬁcally about
which of their medications they have dif-
ﬁcultypayingfor.Forpatientswhoreport
difﬁculty paying for only selected medi-
cations, providers need to further probe
beliefs about prescription drugs, medica-
tion knowledge, medication-speciﬁc con-
cerns, and mood. Clarifying the relative
roles of these factors will help guide the
best strategy for improving medication
use and ultimately outcomes. Dissatisfac-
tion with medication information is an
importantpredictorofCRNforpaintreat-
ments, whereas negative medication be-
liefs are a predictor of CRN for diabetes
therapies; these relationships underscore
the important role of clinician-patient
communication in CRN (22).
Our ﬁndings suggest that cost should
be viewed as one of multiple potential
causes for underuse, rather than a sole
cause, because for some adherence prob-
lems, such as CRN for diabetes only, nei-
ther medication cost nor income was
foundtohavesigniﬁcanteffects.Indeed,a
patient whose predominant reason for
underuse of a medication is experiencing
side effects but who also has concerns
about the price might reasonably report
CRN (9). Although CRN is a timely and
important topic, further research is
needed to clarify how best to isolate the
effect of ﬁnancial factors from that of
other inﬂuences on adherence behavior.
We can only speculate as to the rea-
sons for different patterns of medication
underuse. Income may have only inﬂu-
enced selective CRN of pain but not of
diabetes medications because patients
mayhavefeltthatdiabetesposedagreater
threat to their long-term health, whereas
pain medications provided “only” symp-
tomatic beneﬁt (6,16). Prior studies sug-
gested that patients’ cognitive and
emotional representations of their ill-
nesses may be among the most important
independent predictors of their adher-
ence (23). Unfortunately, these elements
were only measured indirectly in the cur-
rentstudy.Inaddition,patientsmayhave
opted to use cheaper, potentially subop-
timal over-the-counter analgesics to treat
their pain, whereas there were no similar
nonprescriptionalternativesfortheirpre-
scription diabetes medications (16). Indi-
vidualswhowerenotcompletelysatisﬁed
with medication information may have
had greater risk of CRN selectively for
paintreatmentbecausetheymayhaveless
understandingoftheintendeduseoftheir
medications.
Our results build on ﬁndings of prior
studies that depression increases risk of
CRN(4).Theeffectsofdepressionmaybe
mediated by lower self-efﬁcacy, pessi-
mism about reducing long-term health
risks, and increased cynicism about med-
ication effectiveness. Depression is asso-
ciated with disability and loss of income
(24), which may contribute to CRN, but
in our multivariate model, the effects of
depression on CRN were independent of
income. Patients with more negative be-
liefs about prescription medications in
general may have higher rates of CRN be-
cause they perceive less value in their
medications and are, therefore, less will-
ing to pay for them.
This study has a number of limita-
tions. First, as with all survey studies,
there are risks of bias in self-reporting.
Previous studies investigating the accu-
racy of self-reports of medication adher-
ence compared with administrative data
orbiologicalassayshaveshownwidevari-
ation in their estimates (25). Both recall
errorandsocialdesirabilitywouldtendto
causeanoverestimationofmedicationad-
herence, but what effect this would have
onourresultsisunclear.Wecannotmake
claims beyond association for the relation
between CRN and other factors analyzed,
inpartbecauseofdifﬁcultyassertingtem-
porality. These ﬁndings may not be gen-
eralizable to underuse of medications
for conditions other than diabetes and
chronic pain. We could not investigate
the impact of other important patient-
level characteristics, such as trust in cli-
nicians (11), because not all patients
had primary care providers. Drug-
speciﬁcmedicationcopaymentsmayin-
ﬂuence patients’ adherence choices but
unfortunately were not available. Fi-
nally, the study had a low response rate;
becauseofinstitutionalreviewboardre-
strictions, we could not gather data on
study nonparticipants to determine the
extent to which the sample represents
the larger population.
With these caveats, we conclude that
patients using both diabetes and chronic
pain medications who cut back on both
because of cost may be responding pri-
marily to limited income and higher out-
of-pocket costs. In contrast, patients
prescribed both types of treatment who
selectively forgo their diabetes medica-
tionsmaybeaffectedmorebyfactorssuch
as depression and negative beliefs about
prescriptionmedications.Moregenerally,
patients’ response to medication costs is
notuniform:variouspatternsofunderuse
reﬂect different patient concerns. Greater
attentionbyphysicianstopatients’partic-
ular reasons for underuse may lead to
more effective interventions and ulti-
mately better outcomes for diabetic pa-
tients who experience CRN.
Acknowledgments— This study was funded
by the Clinical Research Program of the Ameri-
can Diabetes Association, the Michigan Diabetes
Research and Training Center (National Insti-
tutes of Health [NIH] Grant DK-020572), and
the Michigan Institute for Clinical and Health
Research (NIH Grant UL1-RR- 024986).
J.D.P. is a VA Research Career Scientist.
No potential conﬂicts of interest relevant to
this article were reported.
Parts of this study were presented in ab-
stract form at the 32nd annual meeting of the
Society for General Internal Medicine, Miami,
Florida, 13–16 May 2009.
Sarah Lim, Shimia Isaac, and Mary Jane
Eicher were responsible for patient recruit-
ment and data collection. Dana Striplin pro-
vided overall project management. Drs. Basim
Toﬁq and Michael Giacalone provided invalu-
able support for data collection.
References
1. Paez KA, Zhao L, Hwang W. Rising out-
of-pocket spending for chronic condi-
tions: a ten-year trend. Health Aff
(Millwood) 2009;28:15–25
2. Hartman M, Martin A, McDonnell P, Cat-
lin A. National health spending in 2007:
slower drug spending contributes to low-
est rate of overall growth since 1998.
Health Aff (Millwood) 2009;28:246–261
3. Neuman P, Strollo MK, Guterman S, Rog-
ers WH, Li A, Rodday AM, Safran DG.
Medicare prescription drug beneﬁt
progress report: ﬁndings from a 2006 na-
tional survey of seniors. Health Aff (Mill-
wood) 2007;26:w630–w43
4. Briesacher BA, Gurwitz JH, Soumerai
SB.Patientsat-riskforcost-relatedmed-
ication nonadherence: a review of the
literature. J Gen Intern Med 2007;22:
864–871
5. Piette JD, Heisler M, Wagner TH. Prob-
lems paying out-of-pocket medication
Kurlander and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 12, DECEMBER 2009 2147costs among older adults with diabetes.
Diabetes Care 2004;27:384–391
6. Piette JD, Heisler M, Wagner TH. Cost-
related medication underuse among
chronically ill adults: the treatments peo-
ple forgo, how often, and who is at risk.
Am J Public Health 2004;94:1782–1787
7. Mojtabai R, Olfson M. Medication costs,
adherence, and health outcomes among
Medicare beneﬁciaries. Health Aff (Mill-
wood) 2003;22:220–229
8. TamblynR,LapriseR,HanleyJA,Abraha-
mowicz M, Scott S, Mayo N, Hurley J,
Grad R, Latimer E, Perreault R. Adverse
events associated with prescription drug
cost-sharing among poor and elderly per-
sons. JAMA 2001;285:421–429
9. Piette JD, Heisler M, Horne R, Alexander
GC. A conceptually based approach to
understanding chronically ill patients’ re-
sponses to medication cost pressures. Soc
Sci Med 2006;62:846–857
10. Steinman MA, Sands LP, Covinsky KE.
Self-restriction of medications due to cost
in seniors without prescription coverage.
J Gen Intern Med 2001;16:793–799
11. PietteJD,HeislerM,KreinS,KerrEA.The
role of patient-physician trust in moder-
ating medication nonadherence due to
cost pressures. Arch Intern Med 2005;
165:1749–1755
12. Soumerai SB, Pierre-Jacques M, Zhang F,
Ross-Degnan D, Adams AS, Gurwitz J,
Adler G, Safran DG. Cost-related medica-
tion nonadherence among elderly and dis-
abled Medicare beneﬁciaries: a national
survey1yearbeforetheMedicaredrugben-
eﬁt. Arch Intern Med 2006;166:1829–1835
13. Tseng CW, Tierney EF, Gerzoff RB, Dud-
ley RA, Waitzfelder B, Ackermann RT,
Karter AJ, Piette J, Crosson JC, Ngo-
Metzger Q, Chung R, Mangione CM.
Race/ethnicity and economic differences
in cost-related medication underuse
among insured adults with diabetes: the
Translating Research Into Action for Dia-
betes Study. Diabetes Care 2008;31:261–
266
14. Kennedy J, Morgan S. A cross-national
study of prescription nonadherence due
tocost:datafromthejointCanada-United
States survey of health. Clin Ther 2006;
28:1217–1224
15. Piette JD, Heisler M, Wagner TH. Medi-
cation characteristics beyond cost alone
inﬂuence decisions to underuse pharma-
cotherapy in response to ﬁnancial pres-
sures. J Clin Epidemiol 2006;59:739–
746
16. Goldman DP, Joyce GF, Escarce JJ, Pace
JE, Solomon MD, Laouri M, Landsman
PB, Teutsch SM. Pharmacy beneﬁts and
the use of drugs by the chronically ill.
JAMA 2004;291:2344–2350
17. Alexander GC, Casalino LP, Meltzer DO.
Physician strategies to reduce patients’
out-of-pocket prescription costs. JAMA
2005;165:633–636
18. Horne R, Weinman J. Patients’ beliefs
about prescribed medicines and their role
in adherence to treatment in chronic
physical illness. J Psychosom Res 1999;
47:555–567
19. Horne R, Hankins M, Jenkins R. The Sat-
isfaction with Information about Medi-
cines Scale (SIMS): a new measurement
tool for audit and research. Qual Health
Care 2001;10:135–140
20. Kroenke K, Spitzer RL, Williams JB. Va-
lidity of a brief depression severity mea-
sure.JGenInternMed2001;16:606–613
21. Fortess EE, Soumerai SB, McLaughlin TJ,
Ross-Degnan D. Utilization of essential
medications by vulnerable older people
after a drug beneﬁt cap: importance of
mental disorders, chronic pain, and prac-
tice setting. J Am Geriatr Soc 2001;49:
793–797
22. Wilson IB, Schoen C, Neuman P, Strollo
MK, Rogers WH, Chang H, Safran DG.
Physician-patient communication about
prescription medication nonadherence: a
50-state study of America’s seniors. J Gen
Intern Med 2007;22:6–12
23. Bucks RS, Hawkins K, Skinner TC, Horn
S,SeddonP,HorneR.Adherencetotreat-
ment in adolescents with cystic ﬁbrosis:
the role of illness perceptions and treat-
ment beliefs. J Pediatr Psychol 2009;34:
893–902
24. Whooley MA, Kiefe CI, Chesney MA,
Markovitz JH, Matthews K, Hulley SB.
Depressive symptoms, unemployment,
and loss of income: the CARDIA Study.
Arch Intern Med 2002;162:2614–2620
25. Glintborg B, Hillestrom PR, Olsen LH,
Dalhoff KP, Poulsen HE. Are patients re-
liable when self-reporting medication
use? Validation of structured drug inter-
views and home visits by drug analysis
and prescription data in acutely hospital-
ized patients. J Clin Pharmacol 2007;47:
1440–1449
Choosing medications under ﬁnancial pressure
2148 DIABETES CARE, VOLUME 32, NUMBER 12, DECEMBER 2009 care.diabetesjournals.org